Longboard Pharmaceuticals Stock (NASDAQ: LBPH) stock price, news, charts, stock research, profile.
Open | $35.15 |
Close | $34.79 |
Volume / Avg. | 315.01K / 583.07K |
Day Range | $34.60 - $35.74 |
52 Wk Range | 3.60 - 40.48 |
Market Cap | $1.35B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 16.85% |
Days to Cover | 7.76 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Longboard Pharmaceuticals (NASDAQ:LBPH) through any online brokerage.
Other companies in Longboard Pharmaceuticals’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Rapport Therapeutics (NASDAQ:RAPP), Phibro Animal Health (NASDAQ:PAHC) and Neumora Therapeutics (NASDAQ:NMRA).
Longboard Pharmaceuticals has a consensus price target of $49.00.
The stock price for Longboard Pharmaceuticals (NASDAQ: LBPH) is $34.79 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Longboard Pharmaceuticals.
Longboard Pharmaceuticals’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Longboard Pharmaceuticals.
Longboard Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.